Advertisement
ResearchIn-Press PreviewHematologyInflammationOncology
Open Access |
10.1172/JCI202856
1Department of Pediatrics, Indiana University School of Medicine, Indianapolis, United States of America
2Clinical and Translational Epidemiology Unit, Massachusetts General Hospital, United States of America
3Department of Pediatrics, Herman B Wells Center for Pediatric Research, Indianapolis, United States of America
4Chemical Biology Program, Memorial Sloan Kettering Cancer Center, New York, United States of America
5Clinical and Translational Epidemiology Unit, Massachusetts General Hospital, Kanagawa, Japan
6Program in Medical and Population Genetics and the Cardiovascular Disease I, Broad Institute of Harvard and MIT, Boston, United States of America
7Clinical and Translational Epidemiology Unit, Massachusetts General Hospital, Boston, United States of America
Find articles by Kapur, R. in: PubMed | Google Scholar
1Department of Pediatrics, Indiana University School of Medicine, Indianapolis, United States of America
2Clinical and Translational Epidemiology Unit, Massachusetts General Hospital, United States of America
3Department of Pediatrics, Herman B Wells Center for Pediatric Research, Indianapolis, United States of America
4Chemical Biology Program, Memorial Sloan Kettering Cancer Center, New York, United States of America
5Clinical and Translational Epidemiology Unit, Massachusetts General Hospital, Kanagawa, Japan
6Program in Medical and Population Genetics and the Cardiovascular Disease I, Broad Institute of Harvard and MIT, Boston, United States of America
7Clinical and Translational Epidemiology Unit, Massachusetts General Hospital, Boston, United States of America
Find articles by Li, L. in: PubMed | Google Scholar
1Department of Pediatrics, Indiana University School of Medicine, Indianapolis, United States of America
2Clinical and Translational Epidemiology Unit, Massachusetts General Hospital, United States of America
3Department of Pediatrics, Herman B Wells Center for Pediatric Research, Indianapolis, United States of America
4Chemical Biology Program, Memorial Sloan Kettering Cancer Center, New York, United States of America
5Clinical and Translational Epidemiology Unit, Massachusetts General Hospital, Kanagawa, Japan
6Program in Medical and Population Genetics and the Cardiovascular Disease I, Broad Institute of Harvard and MIT, Boston, United States of America
7Clinical and Translational Epidemiology Unit, Massachusetts General Hospital, Boston, United States of America
Find articles by
Kanumuri, R.
in:
PubMed
|
Google Scholar
|
1Department of Pediatrics, Indiana University School of Medicine, Indianapolis, United States of America
2Clinical and Translational Epidemiology Unit, Massachusetts General Hospital, United States of America
3Department of Pediatrics, Herman B Wells Center for Pediatric Research, Indianapolis, United States of America
4Chemical Biology Program, Memorial Sloan Kettering Cancer Center, New York, United States of America
5Clinical and Translational Epidemiology Unit, Massachusetts General Hospital, Kanagawa, Japan
6Program in Medical and Population Genetics and the Cardiovascular Disease I, Broad Institute of Harvard and MIT, Boston, United States of America
7Clinical and Translational Epidemiology Unit, Massachusetts General Hospital, Boston, United States of America
Find articles by Padam, K. in: PubMed | Google Scholar
1Department of Pediatrics, Indiana University School of Medicine, Indianapolis, United States of America
2Clinical and Translational Epidemiology Unit, Massachusetts General Hospital, United States of America
3Department of Pediatrics, Herman B Wells Center for Pediatric Research, Indianapolis, United States of America
4Chemical Biology Program, Memorial Sloan Kettering Cancer Center, New York, United States of America
5Clinical and Translational Epidemiology Unit, Massachusetts General Hospital, Kanagawa, Japan
6Program in Medical and Population Genetics and the Cardiovascular Disease I, Broad Institute of Harvard and MIT, Boston, United States of America
7Clinical and Translational Epidemiology Unit, Massachusetts General Hospital, Boston, United States of America
Find articles by Ramdas, B. in: PubMed | Google Scholar
1Department of Pediatrics, Indiana University School of Medicine, Indianapolis, United States of America
2Clinical and Translational Epidemiology Unit, Massachusetts General Hospital, United States of America
3Department of Pediatrics, Herman B Wells Center for Pediatric Research, Indianapolis, United States of America
4Chemical Biology Program, Memorial Sloan Kettering Cancer Center, New York, United States of America
5Clinical and Translational Epidemiology Unit, Massachusetts General Hospital, Kanagawa, Japan
6Program in Medical and Population Genetics and the Cardiovascular Disease I, Broad Institute of Harvard and MIT, Boston, United States of America
7Clinical and Translational Epidemiology Unit, Massachusetts General Hospital, Boston, United States of America
Find articles by Pasala, C. in: PubMed | Google Scholar
1Department of Pediatrics, Indiana University School of Medicine, Indianapolis, United States of America
2Clinical and Translational Epidemiology Unit, Massachusetts General Hospital, United States of America
3Department of Pediatrics, Herman B Wells Center for Pediatric Research, Indianapolis, United States of America
4Chemical Biology Program, Memorial Sloan Kettering Cancer Center, New York, United States of America
5Clinical and Translational Epidemiology Unit, Massachusetts General Hospital, Kanagawa, Japan
6Program in Medical and Population Genetics and the Cardiovascular Disease I, Broad Institute of Harvard and MIT, Boston, United States of America
7Clinical and Translational Epidemiology Unit, Massachusetts General Hospital, Boston, United States of America
Find articles by Chiosis, G. in: PubMed | Google Scholar
1Department of Pediatrics, Indiana University School of Medicine, Indianapolis, United States of America
2Clinical and Translational Epidemiology Unit, Massachusetts General Hospital, United States of America
3Department of Pediatrics, Herman B Wells Center for Pediatric Research, Indianapolis, United States of America
4Chemical Biology Program, Memorial Sloan Kettering Cancer Center, New York, United States of America
5Clinical and Translational Epidemiology Unit, Massachusetts General Hospital, Kanagawa, Japan
6Program in Medical and Population Genetics and the Cardiovascular Disease I, Broad Institute of Harvard and MIT, Boston, United States of America
7Clinical and Translational Epidemiology Unit, Massachusetts General Hospital, Boston, United States of America
Find articles by Palam, L. in: PubMed | Google Scholar
1Department of Pediatrics, Indiana University School of Medicine, Indianapolis, United States of America
2Clinical and Translational Epidemiology Unit, Massachusetts General Hospital, United States of America
3Department of Pediatrics, Herman B Wells Center for Pediatric Research, Indianapolis, United States of America
4Chemical Biology Program, Memorial Sloan Kettering Cancer Center, New York, United States of America
5Clinical and Translational Epidemiology Unit, Massachusetts General Hospital, Kanagawa, Japan
6Program in Medical and Population Genetics and the Cardiovascular Disease I, Broad Institute of Harvard and MIT, Boston, United States of America
7Clinical and Translational Epidemiology Unit, Massachusetts General Hospital, Boston, United States of America
Find articles by
Kumar, R.
in:
PubMed
|
Google Scholar
|
1Department of Pediatrics, Indiana University School of Medicine, Indianapolis, United States of America
2Clinical and Translational Epidemiology Unit, Massachusetts General Hospital, United States of America
3Department of Pediatrics, Herman B Wells Center for Pediatric Research, Indianapolis, United States of America
4Chemical Biology Program, Memorial Sloan Kettering Cancer Center, New York, United States of America
5Clinical and Translational Epidemiology Unit, Massachusetts General Hospital, Kanagawa, Japan
6Program in Medical and Population Genetics and the Cardiovascular Disease I, Broad Institute of Harvard and MIT, Boston, United States of America
7Clinical and Translational Epidemiology Unit, Massachusetts General Hospital, Boston, United States of America
Find articles by Koyama, S. in: PubMed | Google Scholar
1Department of Pediatrics, Indiana University School of Medicine, Indianapolis, United States of America
2Clinical and Translational Epidemiology Unit, Massachusetts General Hospital, United States of America
3Department of Pediatrics, Herman B Wells Center for Pediatric Research, Indianapolis, United States of America
4Chemical Biology Program, Memorial Sloan Kettering Cancer Center, New York, United States of America
5Clinical and Translational Epidemiology Unit, Massachusetts General Hospital, Kanagawa, Japan
6Program in Medical and Population Genetics and the Cardiovascular Disease I, Broad Institute of Harvard and MIT, Boston, United States of America
7Clinical and Translational Epidemiology Unit, Massachusetts General Hospital, Boston, United States of America
Find articles by
Natarajan, P.
in:
PubMed
|
Google Scholar
|
1Department of Pediatrics, Indiana University School of Medicine, Indianapolis, United States of America
2Clinical and Translational Epidemiology Unit, Massachusetts General Hospital, United States of America
3Department of Pediatrics, Herman B Wells Center for Pediatric Research, Indianapolis, United States of America
4Chemical Biology Program, Memorial Sloan Kettering Cancer Center, New York, United States of America
5Clinical and Translational Epidemiology Unit, Massachusetts General Hospital, Kanagawa, Japan
6Program in Medical and Population Genetics and the Cardiovascular Disease I, Broad Institute of Harvard and MIT, Boston, United States of America
7Clinical and Translational Epidemiology Unit, Massachusetts General Hospital, Boston, United States of America
Find articles by Haneline, L. in: PubMed | Google Scholar
1Department of Pediatrics, Indiana University School of Medicine, Indianapolis, United States of America
2Clinical and Translational Epidemiology Unit, Massachusetts General Hospital, United States of America
3Department of Pediatrics, Herman B Wells Center for Pediatric Research, Indianapolis, United States of America
4Chemical Biology Program, Memorial Sloan Kettering Cancer Center, New York, United States of America
5Clinical and Translational Epidemiology Unit, Massachusetts General Hospital, Kanagawa, Japan
6Program in Medical and Population Genetics and the Cardiovascular Disease I, Broad Institute of Harvard and MIT, Boston, United States of America
7Clinical and Translational Epidemiology Unit, Massachusetts General Hospital, Boston, United States of America
Find articles by
Yu, Z.
in:
PubMed
|
Google Scholar
|
1Department of Pediatrics, Indiana University School of Medicine, Indianapolis, United States of America
2Clinical and Translational Epidemiology Unit, Massachusetts General Hospital, United States of America
3Department of Pediatrics, Herman B Wells Center for Pediatric Research, Indianapolis, United States of America
4Chemical Biology Program, Memorial Sloan Kettering Cancer Center, New York, United States of America
5Clinical and Translational Epidemiology Unit, Massachusetts General Hospital, Kanagawa, Japan
6Program in Medical and Population Genetics and the Cardiovascular Disease I, Broad Institute of Harvard and MIT, Boston, United States of America
7Clinical and Translational Epidemiology Unit, Massachusetts General Hospital, Boston, United States of America
Find articles by
Pasupuleti, S.
in:
PubMed
|
Google Scholar
|
Published June 23, 2026 - More info
Obesity is increasingly implicated in hematopoietic malignancies, yet its role in mutation-driven myeloid leukemias remains unclear. Using UK Biobank data from over 440,000 individuals, we found obesity traits including elevated BMI and waist-to-hip ratio were associated with type 2 diabetes, increased plasma IL-17A (interleukin-17A), reduced GLP-1R (glucagon like peptide 1 receptor) expression, and heightened risk of myeloid malignancies. Transplantation of protein tyrosine phosphatase non-receptor type 11, PTPN11 (Shp2E76K/+) mutant hematopoietic stem/progenitors into obese mice demonstrated that metabolic inflammation accelerates leukemogenesis via myeloid cell expansion, lipid metabolic rewiring, IL-17A activation, and accumulation of M2-like tumor-associated macrophages (TAMs), accompanied by T-cell exhaustion and impaired antigen presentation. Notably, dual therapy with an anti-IL-17A antibody and a GLP-1R agonist reversed these effects, by reducing M2-like TAMs, restoring Ciita-dependent antigen presentation, Tyk2-mediated IFNγ signaling, reactivated T-cell responses, and reducing leukemic burden. These findings establish IL-17A driven, metabolism-coupled immunosuppression as a mechanistic link between obesity and SHP2-mutant myeloid leukemias, highlighting a tractable therapeutic strategy for high-risk obese patients.